Apoptosis in selected liver diseases

被引:6
作者
Kilicarslan, Alp [1 ,2 ]
Kahraman, Alisan [1 ]
Akkiz, Hikmet [3 ]
Menziletoglu, Sule Yildiz [4 ]
Fingas, Christain D. [1 ]
Gerken, Guido [1 ]
Canbay, Ali [1 ]
机构
[1] Univ Hosp Essen, Div Gastroenterol & Hepatol, Essen, Germany
[2] Hacettepe Univ, Sch Med, Dept Internal Med, Ankara, Turkey
[3] Cukurova Univ, Sch Med, Div Gastroenterol & Hepatol, Adana, Turkey
[4] Cukurova Univ, Sch Med, Dept Biochem, Adana, Turkey
关键词
Apoptosis; non-alcoholic steatohepatitis; HBV; HCV; hepatocellular carcinoma; alcoholic liver disease; C VIRUS-INFECTION; NF-KAPPA-B; HEPATIC STELLATE CELLS; SEVERE ALCOHOLIC HEPATITIS; FAS-MEDIATED APOPTOSIS; NECROSIS-FACTOR-ALPHA; HEPATOCELLULAR-CARCINOMA; HEPATOCYTE APOPTOSIS; CASPASE ACTIVATION; NONALCOHOLIC STEATOHEPATITIS;
D O I
10.4318/tjg.2009.0003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cell death by apoptosis usually occurs in a regulated, limited fashion. Only selected target cells are deleted in the process of ontogeny, development and regeneration. In contrast, under pathophysiological conditions, apoptosis imposes as a massive, chaotic, non-selective event that may occur for periods or even up to decades. It is likely that apoptosis is the initial cellular response to injury and may thus initiate several, intertwined cellular and cytokine cascades that culminate in tissue injury, inflammation, fibrosis and finally, in cirrhosis. Obviously, this cascade of events is of particular importance in various types of acute and chronic liver diseases. In contrast, defective apoptosis and increased cell proliferation is associated with cancer. Indeed, tumor cells often show alterations in genes regulating the apoptosis machinery. This overview is focused on the role of apoptosis in select important liver diseases. Today, rational-based strategies are being developed to either promote or suppress apoptotic cell death as a novel therapeutic option in the treatment of these liver diseases.
引用
收藏
页码:171 / 179
页数:9
相关论文
共 100 条
  • [1] The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis
    Adams, LA
    Angulo, P
    Abraham, SC
    Torgerson, H
    Brandhagen, D
    [J]. LIVER INTERNATIONAL, 2006, 26 (03) : 298 - 304
  • [2] The natural history of nonalcoholic fatty liver disease: A population-based cohort study
    Adams, LA
    Lymp, JF
    St Sauver, J
    Sanderson, SO
    Lindor, KD
    Feldstein, A
    Angulo, P
    [J]. GASTROENTEROLOGY, 2005, 129 (01) : 113 - 121
  • [3] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [4] Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury
    Bantel, H
    Lügering, A
    Heidemann, J
    Volkmann, X
    Poremba, C
    Strassburg, CP
    Manns, MP
    Schulze-Osthoff, K
    [J]. HEPATOLOGY, 2004, 40 (05) : 1078 - 1087
  • [5] Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection
    Bantel, H
    Lügering, A
    Poremba, C
    Lügering, N
    Held, J
    Domschke, W
    Schulze-Osthoff, K
    [J]. HEPATOLOGY, 2001, 34 (04) : 758 - 767
  • [6] Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells
    Bechmann, Lars P.
    Zahn, Denis
    Gieseler, Robert K.
    Fingas, Christian D.
    Marquitan, Guido
    Jochum, Christoph
    Gerken, Guido
    Friedman, Scott L.
    Canbay, Ali
    [J]. HEPATOLOGY RESEARCH, 2009, 39 (06) : 601 - 608
  • [7] Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: Inhibition of cell proliferation and induction of apoptosis
    Bishayee, Anupam
    Dhir, Neetika
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 179 (2-3) : 131 - 144
  • [8] Dysregulation of growth factor signaling in human hepatocellular carcinoma
    Breuhahn, K.
    Longerich, T.
    Schirmacher, P.
    [J]. ONCOGENE, 2006, 25 (27) : 3787 - 3800
  • [9] Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x
  • [10] Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression
    Canbay, A
    Feldstein, AE
    Higuchi, H
    Werneburg, N
    Grambihler, A
    Bronk, SF
    Gores, GJ
    [J]. HEPATOLOGY, 2003, 38 (05) : 1188 - 1198